Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database - Ishibashi, Ryoichi; Inaba, Yosuke; Koshizaka, Masaya; Takatsuna, Yoko; Tatsumi, Tomoaki; Shiko, Yuki; Kashiwagi, Yusuke; Maezawa, Yoshiro; Kawasaki, Yohei; Kawakami, Eiryo; Yamamoto, Shuichi; Yokote, Koutaro (Diabetes, Obesity & Metabolism, 2024)